Overview
Chihiro Taka practices in Toyama, Japan. Ms. Taka is rated as an Advanced expert by MediFind in the treatment of IgG4-Related Disease. Her top areas of expertise are IgG4-Related Disease, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and Pure Red Cell Aplasia.
Her clinical research consists of co-authoring 28 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- IgG4-Related DiseaseMs. Taka isAdvanced. Learn about IgG4-Related Disease.
- Experienced
- Lung CancerMs. Taka isExperienced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Ms. Taka isExperienced. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Pure Red Cell AplasiaMs. Taka isExperienced. Learn about Pure Red Cell Aplasia.
- RhabdomyosarcomaMs. Taka isExperienced. Learn about Rhabdomyosarcoma.
- Small Cell Lung Cancer (SCLC)Ms. Taka isExperienced. Learn about Small Cell Lung Cancer (SCLC).